Cited by 953Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Open access
Rosenson, Robert S., Brewer, H. Bryan, Davidson, W. Sean, Fayad, Zahi A., Fuster, Valentin, Goldstein, James, Hellerstein, Marc, Jiang, Xian-Cheng +6 more·2012·Circulation

Abstract

proposed a concept of RCT in overall flux of cholesterol from the entire From Mount Sinai Heart (

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.111.066589

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RCT is the only mechanism by which arterial macrophages can remove excess cholesterol, thereby reducing the formation of atherosclerotic plaques by limiting the accumulation of lipid-laden macrophages within the arterial wall.

    “RCT is the only mechanism by which arterial macrophages (Mθs) can remove excess cholesterol, thereby reducing the formation of atherosclerotic plaques by limiting the accumulation of lipid-laden Mθs within the arterial wall (Rosenson et al., 2012).”

    From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Rosenson et al., 2012

    The Cellular Cholesterol Efflux section (page unavailable) places removal of excess cholesterol from plaque macrophages within the concept of RCT and describes several efflux pathways. The Experimental Animal Models of RCT section links greater macrophage RCT with atheroprotection. Neither section establishes that RCT is the only mechanism by which arterial macrophages can remove excess cholesterol. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • HDL can protect against atherosclerosis by multiple mechanisms, including the ability to efflux cholesterol from endothelial macrophages (macrophage reverse cholesterol transport), or through anti-inflammatory, antioxidative and antiapoptotic pathways.

    “HDL can protect against atherosclerosis by multiple mechanisms, including the ability to efflux cholesterol from endothelial macrophages (macrophage reverse cholesterol transport)43, or through anti-inflammatory44, antioxidative45 and antiapoptotic46 pathways.”
  • This route of removal of cholesterol (macrophage RCT) has been regarded as an important (but not only) component in retaining cholesterol balance in arterial endothelium.

    “However, this route of removal of cholesterol (macrophage RCT) has been regarded as an important (but not only) component in retaining cholesterol balance in arterial endothelium43.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., Remaley, A. T., Rothblat, G. H., Tall, A. R., & Yvan-Charvet, L.
Affiliations
  • Oakland University (US)
  • From Mount Sinai Heart (R.S.R., V.F.) and the Translational and Molecular Imaging Institute (Z.A.F.), Mount Sinai School of Medicine, New York, NY; Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC (H.B.B.); Center for Lipid and Arteriosclerosis Science, University of Cincinnati, Cincinnati, OH (W.S.D.); Oakland University William Beaumont School of Medicine, William Beaumont Hospital, Royal Oak, MI (J.G.); University of California Berkeley,...
Venue
Circulation
Published
2012-04-17
Volume
125
Issue
15
Pages
1905-1919
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1989242866
Cited by
953
References
150
Citations by year
2026: 43 · 2025: 54 · 2024: 56 · 2023: 63 · 2022: 49 · 2021: 85 · 2020: 57 · 2019: 57 · 2018: 69 · 2017: 74 · 2016: 58 · 2015: 88 · 2014: 88 · 2013: 91 · 2012: 20
FWCI
17.76
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Amgen
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Regeneron Pharmaceuticals
  • KineMed
  • Medicines Company
  • National Institutes of Health
  • Genentech
  • National Heart, Lung, and Blood Institute (ZIAHL006095)
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
cholesterol efflux, atheroprotection, reverse cholesterol transport, atherosclerosis
MeSH terms
ATP Binding Cassette Transporter, Subfamily G, Member 1, Animals, Biological Transport, Cholesterol, Diffusion, Humans, Lipoproteins, HDL, Macrophages, ATP-Binding Cassette Transporters, Models, Animal, Phospholipid Transfer Proteins, Atherosclerosis, Scavenger Receptors, Class B, Cholesterol Ester Transfer Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review